Krishna N. Das: Latest News, Top News, Photos, Videos by Krishna N. Das

Krishna N. Das

A health worker administers COVISHIELD vaccine to an elderly man at the Guwahati Medical College hospital in Gauhati. (AP)

Covid vaccinations in India fall from peak as infections hit record

2 min read . Updated: 16 Apr 2021

COVAX has so far received 17.7 million AstraZeneca doses from SII (REUTERS)

India delays big exports of Serum's Covishield doses as infections surge: Report

1 min read . Updated: 24 Mar 2021

A woman receives Covid- 19 vaccine at a government hospital (AP)

Odisha warns of Covid-19 vaccine shortage, immunisation halt

2 min read . Updated: 23 Mar 2021

SII has supplied half of the 10 million doses recently ordered by Britain (Photo: Reuters)

'Serum Institute to delay further vaccine shipments to Brazil, Morocco, Saudi'

1 min read . Updated: 21 Mar 2021

Pfizer pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its request to skip a small local safety trial (Photo: Reuters)

Pfizer wants to make covid-19 vaccine in India if faster clearance assured

2 min read . Updated: 10 Mar 2021

Sister P Niveda, the main nurse administered Bharat BioTech's Covaxin to PM Modi

Modi's ministers choose 'Made in India' vaccine over AstraZeneca

1 min read . Updated: 03 Mar 2021

At more than 11 million, India has reported the highest number of cases in the world after the United States. (Photo: PTI)

India's next phase of virus crisis likely to be localised outbreaks: Experts

3 min read . Updated: 02 Mar 2021

For Indian pharma firms, while stemming a sales decline may be difficult, improving profits could be possible. The risk is if prices fall significantly more than the companies anticipate and wipe out cost savings. Photo: Bloomberg

Indian pharma firms go local seeking to end reliance on China

1 min read . Updated: 23 Feb 2021

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN during a vaccination campaign at AIIMS Delhi (Reuters)

Indian vaccine makers say can quickly adapt to tackle Covid variants

1 min read . Updated: 22 Feb 2021

Prime Minister Narendra Modi (ANI Photo)

PM Modi calls for vaccine data sharing as exports increase

1 min read . Updated: 18 Feb 2021

India's COVID-19 cases rose by 9,121 in the past 24 hours, taking the total to 10.93 million. Deaths rose by 81 to 155,813. (Photo: ANI)

Govt to increase Covid vaccination sites by up to 5 times amid coverage concerns

2 min read . Updated: 16 Feb 2021

Vials of AstraZeneca's Covishield coronavirus (COVID-19) vaccine, are seen before they are packaged inside a lab at Serum Institute of India. (REUTERS)

UK considering to get made-in-India Covid vaccine: Report

3 min read . Updated: 15 Feb 2021

The human trials of Covaxin has begun at the All India Institute of Medical Sciences, Patna

Chhattisgarh rejects Bharat Biotech vaccine approved without efficacy data

1 min read . Updated: 11 Feb 2021

A policeman receives a dose of COVISHIELD, a COVID-19 vaccine manufactured by Serum Institute of India, at a vaccination centre in Ahmedabad. (REUTERS)

India orders 14.5 million more COVID-19 vaccine doses as campaign expands

1 min read . Updated: 09 Feb 2021

Over 300 million Indians may have Covid-19: Report

1 min read . Updated: 03 Feb 2021

India has reported 10.8 million COVID-19 infections, the most anywhere outside the United States (Photo: AFP)

Over half in New Delhi may have had Covid, serological survey suggests

1 min read . Updated: 02 Feb 2021

Pfizer wants India to order its COVID vaccine before pursuing approval: Report

2 min read . Updated: 25 Jan 2021

The vaccination programme started on Saturday, with 30 million healthcare and other front-line workers first in the queue

Govt urges frontline workers not to refuse Covid-19 vaccines as targets missed

1 min read . Updated: 19 Jan 2021

India plans foreign investment rule changes that could hit Amazon

3 min read . Updated: 19 Jan 2021

Administering Bharat Biotech's COVAXIN, has worried some health experts who consider it rushed, as the vaccine has only limited, 'clinical-trial mode' approval (Photo: PTI)

Govt to treat Bharat Biotech's Covaxin same as AstraZeneca's

3 min read . Updated: 14 Jan 2021

My Reads Redeem a Gift Card Logout